PTCE PTCB Pharmacy Technician Certification (CPhT) Exam Free Practice Exam Questions (2026 Updated)

Amlodipine (Norvasc)is acalcium channel blocker (CCB)used to treathypertension and angina. A common side effect of amlodipine isdizziness, which occurs due to itsvasodilatory effects, leading tolowered blood pressureandpotential orthostatic hypotension.

B. Photosensitivity→ Incorrect;photosensitivityis more commonly associated with drugs such astetracyclines, sulfonamides, and fluoroquinolones, not amlodipine.

C. Agitation→ Incorrect; amlodipine does not typically causeCNS agitation.

D. Insomnia→ Incorrect;amlodipine does not significantly affect sleep patterns.

Peripheraledema

Flushing

Fatigue

Other Answer Choices Explained:Additional Side Effects of Amlodipine:References:

PTCB PTCE Exam Content Outline (Pharmacology for Technicians – Cardiovascular System Drugs)

Lexicomp Drug Monograph for Amlodipine

Goodman & Gilman’s The Pharmacological Basis of Therapeutics

When adrug recalloccurs due totemperature excursions(exposure to temperatures outside the manufacturer’s recommended range during transport or storage), the pharmacy mustimmediately remove all affected productfrom its inventory to prevent dispensing compromised medication.

Remove the Affected Product:Quarantine the recalled drug to ensure it is not dispensed.

Verify the Recall Details:Confirm the lot number, expiration date, and reason for the recall using FDA or manufacturer recall notices.

Document the Recall Action:Log details in the pharmacy's recall records for compliance.

Follow Manufacturer or FDA Instructions:Some recalls require returning the product, while others require disposal according to hazardous waste guidelines.

Notify Patients and Providers (If Necessary):If the medication has already been dispensed, further action may be needed depending on recall severity.

B. Contact patients who received a therapeutically equivalent product.→ Incorrect. The recall applies to thespecificaffected lot, not all similar medications. Pharmacists would first verify which patients received the recalled drugbefore contacting them.

C. Switch patients from the oral solution to oral capsules.→ Incorrect. The recall does not automatically require a formulation change. The pharmacy must verify availability of unaffected stock or alternative treatments before making substitutions.

D. Contact all prescribers who recently prescribed the product.→ Incorrect. While prescribersmayneed notification if the recall affects patient treatment, thefirst stepis ensuring the recalled product is removed from stock to prevent further dispensing.

PTCB PTCE Exam Content Outline – Medication Safety and Recall Procedures.

FDA Drug Recall Guidelines (www.fda.gov).

USP <1079> Good Storage and Distribution Practices for Pharmaceuticals.

National Association of Boards of Pharmacy (NABP) Recall Compliance Standards.

Manufacturer Recall Notices (Example: Pfizer, Eli Lilly, etc.).

Mosby’s Pharmacy Technician: Principles and Practice – Recall Classifications and Actions.

Steps to Follow in a Drug Recall:Why the Other Answer Choices Are Incorrect:Pharmacy Technician References:

Repatha (evolocumab) is a PCSK9 inhibitor used for lowering LDL cholesterol. One of its common side effects includes musculoskeletal pain, such as muscle aches and cramps. According to the FDA package insert for Repatha, clinical trials observed arthralgia, myalgia, and back pain as notable adverse events.

In contrast:

Requip (ropinirole) may cause dizziness or nausea.

Restasis (cyclosporine ophthalmic) causes eye irritation.

Restoril (temazepam) is associated with sedation.

According toUSP <800>andOSHA guidelines, exposure control forhazardous drugs (HDs)must begin as soon as the drugenters the facilityto ensure proper handling, storage, and administration safety. This includes:

Receiving:

Hazardous drugs must beunpacked in a designated areathat isseparate from regular medications.

They shouldnot be opened in sterile or positive-pressure areasto prevent contamination.

Storage:

HDs must be stored in anegative-pressure room with proper ventilation.

They must be placed indesignated binsto reduce exposure risks.

Handling and Compounding:

Usepersonal protective equipment (PPE)such as gloves, gowns, and masks when handling hazardous drugs.

Use abiological safety cabinet (BSC) or compounding aseptic containment isolator (CACI)when preparing hazardous drugs.

A. Is dispensed→ Incorrect;control measures must start earlier, before dispensing.

C. Is compounded→ Incorrect; safety measures beginbefore compounding, when the drug arrives at the pharmacy.

D. Is placed on the pharmacy shelf→ Incorrect;exposure control measuresbegin before storage, duringreceiving and handling.

Other Answer Choices Explained:References:

USP <800> Hazardous Drug Handling Guidelines

OSHA Hazardous Drug Safety Standards

NIOSH (National Institute for Occupational Safety and Health) Hazardous Drug List

PTCB PTCE Exam Content Outline (Medication Safety & Hazardous Drug Handling)

Ketorolac (Toradol) is a nonsteroidal anti-inflammatory drug (NSAID) available in:

Oral tablets

Injectable IM/IV formsIt’s commonly used for short-term pain relief.

The others:

Dobutamine – IV only (used in cardiac settings)

Benzonatate – Oral capsules only (cough suppressant)

Cefazolin – Injectable only (no oral form; used in perioperative antibiotic prophylaxis)

From Mosby’s Pharmacy Technician:

“Ketorolac is one of the few NSAIDs that comes in both oral and parenteral forms, making it useful for step-down therapy in pain management.”

Tetracyclines, includingdoxycycline and minocycline, are broad-spectrum antibiotics used to treat bacterial infections. They have amajor drug-drug interaction with calcium-containing antacidsand other minerals.

Chelation Effect:Calcium binds to tetracycline, forminginsoluble complexesthat prevent the antibiotic from being absorbed in thegastrointestinal (GI) tract.

Reduced Efficacy:Because the drug cannot be absorbed, the antibiotic’s effectiveness is significantly reduced.

Similar Interactions:Magnesium, iron, and aluminum (found in many antacids, dairy products, and multivitamins) also reduce tetracycline absorption.

Take on an Empty Stomach(1 hour before or 2 hours after meals).

Avoid Dairy, Antacids, and Multivitaminsfor at least2 hours before and aftertaking tetracycline.

Drink with a Full Glass of Waterto prevent esophageal irritation.

B. Decongestants that contain pseudoephedrine.→ Incorrect. Pseudoephedrine does not interact with tetracycline.

C. Antitussives that contain dextromethorphan.→ Incorrect. Dextromethorphan does not affect tetracycline absorption.

D. Analgesics that contain acetaminophen.→ Incorrect. Acetaminophen does not bind to tetracycline or impact its absorption.

Lexicomp Drug Interaction Database – Tetracycline and Calcium Interactions.

FDA Drug Label for Tetracycline – Absorption and Drug Interaction Warnings.

Mosby’s Pharmacy Technician: Principles and Practice – Tetracycline Pharmacology.

PTCB PTCE Exam Content Outline – Drug Interactions and Contraindications.

Why Should Tetracycline Not Be Taken with Calcium-Containing Antacids?Patient Counseling for Tetracycline Use:Why the Other Answer Choices Are Incorrect:Pharmacy Technician References:

]

A medication'sstabilityrefers tohow well it maintains potency, effectiveness, and safety over time. Several factors candegrade medications, includingoxygen, moisture, temperature, and light.

Oxygen exposurecan causeoxidation, leading to drug degradation and loss of potency.

Many medications, especiallyvitamins (e.g., vitamin C), biologics, and certain antibiotics, are susceptible to oxidative damage.

Medications requiring protection from oxygen are often packaged inair-tight containersorblister packs.

A. Allergies→ Incorrect; allergies affect thepatient, not the drug’sstability.

B. Equivalence→ Incorrect; equivalence refers tobioavailabilitybetween generic and brand-name drugs, not drug stability.

D. Indications→ Incorrect; indications refer toapproved uses of a drug, not factors affecting its stability.

Other Answer Choices Explained:References:

USP <797> and <795> Guidelines on Medication Stability

FDA Drug Stability and Shelf Life Guidelines

PTCB PTCE Exam Content Outline (Medication Storage & Stability)

Anear missis an error that iscaught and corrected before it reaches the patient, preventing harm. In this case, the pharmacistidentified that ampicillin was incorrectly entered as amoxicillinandcorrected the error before dispensing, meaning the patient never received the wrong medication.

B. Dispensing error→ Incorrect; adispensing erroroccursonly if the incorrect drug is given to the patient. Since the error was caught before dispensing, it is classified as anear miss.

C. Adverse event→ Incorrect; anadverse eventis aharmful effectexperienced by the patient, which did not happen here.

D. Unauthorized drug→ Incorrect; anunauthorized drugrefers to a drugdispensed without a valid prescription, which is not the case here.

Other Answer Choices Explained:References:

ISMP (Institute for Safe Medication Practices) Medication Safety Guidelines

FDA Medication Error Reporting and Prevention Guidelines

PTCB PTCE Exam Content Outline (Quality Assurance & Medication Safety – Error Prevention)

The abbreviation"PO"means"by mouth" (per os).

The abbreviation"ac"stands for"before meals" (ante cibum).

The phrase"daily for 14 days"indicates that the patient should take the medication once a day for a total of 14 days.

Thus, the correct label instructions should be:"Take one capsule by mouth before a meal once daily for 14 days."

PTCB PTCE Exam Content Outline – Prescription Interpretation– Covers standard medical abbreviations.

ISMP (Institute for Safe Medication Practices) List of Common Pharmacy Abbreviations– Defines "PO" (by mouth) and "ac" (before meals).

USP Medication Labeling Standards– Ensures clear and accurate patient instructions.

Pharmacy Technician References:

Cefdinir is a third-generation cephalosporin antibiotic commonly used to treat bacterial infections, including otitis media (middle ear infection) in children. It is available in both capsule and suspension forms. However, cefdinir suspension is supplied in different concentrations, typically125 mg/5 mLand250 mg/5 mL.

The prescription provided specifies"Cefdinir suspension 5 mL PO q12h x 10 days", but it does not mention the concentration (strength) of the suspension. Without this crucial information, the pharmacy cannot accurately determine the total dosage the patient will receive. Different strengths would result in significantly different amounts of cefdinir per dose.

For example:

If the prescriber intended125 mg/5 mL, then the patient would receive125 mg per dose (250 mg daily).

If the prescriber intended250 mg/5 mL, then the patient would receive250 mg per dose (500 mg daily).

This discrepancy could lead tounderdosing or overdosing, making it essential for the pharmacy to contact the prescriber to confirm the correct concentration before dispensing.

A. Cefdinir is not available as a suspension.→ Incorrect. Cefdinir is available inoral suspensionform, typically in 125 mg/5 mL and 250 mg/5 mL concentrations.

C. Cefdinir suspension is not indicated for otitis media.→ Incorrect. Cefdinir is FDA-approved for the treatment of otitis media in pediatric patients.

D. Cefdinir suspension was prescribed for a child old enough to swallow capsules.→ Incorrect. While some 8-year-old children may be able to swallow capsules, many pediatric patients prefer liquid formulations, and prescribers often choose suspensions for better compliance.

PTCB PTCE Exam Content Outline – Medication Order Entry and Fill Process(Ensuring accuracy of prescriptions, including strength and formulation).

FDA Drug Label for Cefdinir– Indicates available strengths and dosing requirements.

Lexicomp Drug Information for Cefdinir– Lists the recommended pediatric dosages and available suspension concentrations.

Pharmacology Textbooks (e.g., "Mosby’s Pharmacy Technician: Principles and Practice")– Reinforce the importance of verifying missing prescription details before dispensing.

Why the Other Answer Choices Are Incorrect:Pharmacy Technician References:

In the providedcompounded prescription, the antifungal agent isnystatin.

Nystatin is a polyene antifungalthat works by binding toergosterolin fungal cell membranes, causing leakage of cellular contents and fungal cell death.

It iscommonly used for fungal infections, particularlycutaneous or mucosal Candida infections(e.g., diaper rash, oral thrush).

A. Cholestyramine.→ Incorrect. Cholestyramine is abile acid sequestrantused to lowercholesteroland treatdiarrhea(often in combination with other ingredients for skin irritation or wounds).

B. Hydrocortisone.→ Incorrect. Hydrocortisone is acorticosteroidused to reduceinflammation and itching, but it does not kill fungi.

C. Zinc oxide.→ Incorrect. Zinc oxide is askin protectantused fordiaper rash and minor burns, but it is not an antifungal.

Lexicomp Drug Database – Nystatin Mechanism of Action.

FDA Drug Label for Nystatin – Antifungal Properties.

PTCB PTCE Exam Content Outline – Compounded Preparations and Active Ingredients.

Mosby’s Pharmacy Technician: Principles and Practice – Dermatologic Compounding.

Why Is Nystatin an Antifungal?Why the Other Answer Choices Are Incorrect:Pharmacy Technician References:Conclusion:Pharmacy technicians must befamiliar with drug classificationsto correctly identify active ingredients incompounded prescriptions.Nystatin is the only antifungal agentin the provided formulation.

Lamivudine (Epivir)is anantiretroviral agent used to treat HIV/AIDS and hepatitis B. Some antiretroviral drugs are classified ashigh-alert medications in certain healthcare settingsbecause:

Dosing errors can lead to treatment failure or resistance.

Severe side effects and toxicities may occur if misused.

TheInstitute for Safe Medication Practices (ISMP)includes some antiretrovirals in theirhigh-alert medication list, especially in hospitals.

A. Meperidine❌→Not an antiretroviral; it's a narcotic analgesic (opioid pain reliever).

B. Olopatadine❌→Not an antiretroviral; it's an antihistamine (used for allergies).

D. Tizanidine❌→Not an antiretroviral; it's a muscle relaxant.

ISMP High-Alert Medication List– Includes certainantiretroviral drugs as high-alert medications in some settings.

FDA Drug Labeling for Lamivudine (Epivir)– ListsHIV/AIDS and Hepatitis B as indications.

PTCB PTCE Exam Content Outline– Covers high-alert medications and their risks.

Why Not the Other Options?Key References:

• In medication safety terminology used across pharmacy technician study materials and safety taxonomies, an adverse event (specifically, a preventable adverse drug event) occurs when a medication error reaches the patient and results in harm or has the clear potential for harm (e.g., incorrect patient’s medication taken for several doses).

• By contrast, near misses (or “close calls”) are errors that are intercepted before they reach the patient, such as when a pharmacist catches incorrect directions during counseling (Option A), when a technician detects that a prescription was bagged but not yet verified (Option C), or when a technician finds a prescription placed in the wrong will-call bin before pickup (Option D). These represent process breakdowns with potential for harm but no patient exposure once intercepted.

• Therefore, the scenario most likely to lead to an adverse event is Option B, where the patient has already ingested medication intended for another patient. That constitutes an error that reached the patient, with a meaningful risk of harm, aligning with definitions for preventable adverse drug events.

References (Pharmacy Technician documents/Study Guides):

• NCC MERP (National Coordinating Council for Medication Error Reporting and Prevention) Taxonomy and definitions on medication errors, near misses, and events reaching the patient.

• ISMP (Institute for Safe Medication Practices) medication safety terminology and event classification used in community and institutional pharmacy practice.

• PTCB/ExCPT-aligned Pharmacy Technician Certification study guides: sections on medication safety, event reporting, and error prevention (definitions of “adverse event,” “medication error,” and “near miss/close call”).

• ASHP guidelines on preventing medication errors in community pharmacy workflows (verification steps, counseling interception points, and will-call bin best practices).

Look-alike/sound-alike (LASA) medications pose asignificant risk of medication errors. To reduce this risk, pharmacies should:

Use both brand and generic nameson labels to clarify drug identity.

Example:"Celexa (Citalopram)" vs. "Celebrex (Celecoxib)."

B. Place the drug next to another look-alike/sound-alike drug on the shelf if they are alphabetical.❌→Incorrect

LASA drugs shouldnotbe stored next to each other.

Example:Hydroxyzine and Hydralazine should be stored separatelyto avoid mix-ups.

C. Review the first five digits of the NDC to confirm the correct product.❌→Incorrect

The first five digits (manufacturer code) only identify the manufacturer, not the specific drug.

Instead, checking theentire NDC (all 10-11 digits) is necessary.

D. Take hazardous drug precautions.❌→Incorrect

LASA errors are a labeling issue, not a hazardous drug issue.

Institute for Safe Medication Practices (ISMP) LASA Guidelines– Recommends usingboth brand and generic names on labels.

FDA & Joint Commission LASA Drug Safety Recommendations– Emphasizes labeling improvements for LASA drugs.

PTCB PTCE Exam Content Outline– Covers medication safety and error prevention strategies.

Why Not the Other Options?Key References:

Tall Man letteringis amedication safety strategyrecommended by theFDA, ISMP (Institute for Safe Medication Practices), and The Joint Commissiontoprevent medication errorscaused bylook-alike, sound-alike (LASA) drug names.

Thedistinctive portionsof similar drug names are written inuppercase lettersto highlight differences.

Helps pharmacists, technicians, and healthcare professionals distinguish medications that areeasily confuseddue to similar names.

Reduces the risk ofprescription misinterpretationandmedication errorsin pharmacy settings.

How Tall Man Lettering Works:Examples of Tall Man Lettering (ISMP and FDA-Approved List):Regular Name

Tall Man Lettering Version

prednisone

predniSONE

prednisolone

prednisoLONE

hydroxyzine

hydrOXYzine

hydralazine

hydrALAzine

dobutamine

dobutAMINE

dopamine

dopaMINE

A. Highlights the similarities in drug names.→ Incorrect. Tall Man lettering highlightsdifferences, not similarities, toprevent confusion.

B. Ensures all trade names will be capitalized.→ Incorrect. Tall Man lettering applies toboth brand and generic names, but it is used specifically for drugs with look-alike names.

D. Keeps the pharmacy inventory in alphabetic order.→ Incorrect. Inventory order is based onstandard drug names, not Tall Man lettering.

Institute for Safe Medication Practices (ISMP) – Official Tall Man Lettering List.

FDA and The Joint Commission Medication Safety Guidelines.

PTCB PTCE Exam Content Outline – Medication Safety Strategies.

USP <797> and ISMP Guidelines on Look-Alike, Sound-Alike Medications.

Mosby’s Pharmacy Technician: Principles and Practice – Error Prevention Strategies.

Why the Other Answer Choices Are Incorrect:Pharmacy Technician References:Conclusion:Tall Man lettering is anessential tool for pharmacy techniciansto helpreduce medication errorsby drawing attention todifferencesbetweensimilar drug names, ensuringsafer dispensing and administrationof medications.

Under the federal Controlled Substances Act, schedules are codified in Title 21 of the Code of Federal Regulations (CFR), Part 1308. Schedule II substances are those with a high potential for abuse, with use potentially leading to severe psychological or physical dependence, and which have accepted medical uses in the United States. Methadone is explicitly listed as a Schedule II opioid analgesic. By contrast, metoprolol (a beta-blocker), metformin (a biguanide antidiabetic), and methotrexate (an antimetabolite) are not controlled substances under federal scheduling.

High-alert medications are those that bear a heightened risk of causing significant patient harm when used in error. Parenteral potassium chloride (KCl) for injection is a classic example on institutional high-alert lists due to the risk of fatal cardiac arrhythmias with inadvertent bolus administration, concentration mix-ups, or compounding errors. This designation is not based on name similarity (A), packaging color schemes (B), or prescribing preference (C), but on the severity of harm from errors.

Under federal DEA requirements for transferring controlled substance prescriptions in Schedules III–V, the receiving pharmacist must document key original prescription details, including the date of original dispensing, the original date of issuance, the original number of refills authorized, the number of refills remaining, and pertinent information about the transferring pharmacy (name, address, DEA, and Rx number), as well as the name of the transferring pharmacist. Information such as the medication’s expiration date or the receiving pharmacy’s DEA number is not required to be newly noted by the receiving pharmacy for the transfer record. The prescriber’s DEA number is part of the original prescription, but federal transfer documentation specifically requires noting the original dispensing date rather than re-recording the prescriber’s DEA.

References (Pharmacy Technician documents / Study Guides):

• DEA regulations for transfers of Schedule III–V prescriptions (21 CFR 1306.25) — required information for transferring and receiving pharmacists.

• PTCB/ExCPT prep materials: controlled substance prescription transfer documentation requirements.

To determine how muchdrug (active ingredient)is in2 oz (ounces) of cream, we use the given ratio and perform unit conversions.

120 gof cream contains3 gof drug.

2 ozof cream =2 × 28.35 g(since1 oz = 28.35 g)

2 oz = 56.7 g

Step 1: Identify Given DataStep 2: Set Up a Proportion3 g drug120 g cream=x g drug56.7 g cream\frac{3 \text{ g drug}}{120 \text{ g cream}} = \frac{x \text{ g drug}}{56.7 \text{ g cream}}120 g cream3 g drug​=56.7 g creamx g drug​

Step 3: Solve forxxxx=3×56.7120=170.1120=1.42≈1.5 gx = \frac{3 \times 56.7}{120} = \frac{170.1}{120} = 1.42 \approx 1.5 \text{ g}x=1203×56.7​=120170.1​=1.42≈1.5 g

Thus,1.5 g of drugis present in2 oz of cream.

B. 6 g→ Incorrect; this would assume a higher drug concentration.

C. 15 g→ Incorrect; this is a miscalculation of the ratio.

D. 60 g→ Incorrect; far exceeds the total weight of the cream.

Other Answer Choices Explained:References:

PTCB PTCE Exam Content Outline (Pharmaceutical Calculations – Ratios and Proportions)

United States Pharmacopeia (USP) General Chapters on Compounding

The Pharmacy Technician’s Pocket Drug Reference